Similar articles

• Current controversies: levodopa in the treatment of Parkinson's disease.

  Sharma JC, Vassallo M, Ross IN. Sharma JC, et al. Mov Disord. 2005 May;20(5):642-3; author reply 643-4. doi: 10.1002/mds.20444. Mov Disord. 2005. PMID: 15732129 No abstract available.
• Ropinirole as compared with levodopa in Parkinson's disease.

  Hiner BC, Earnhart M. Hiner BC, et al. N Engl J Med. 2000 Sep 21;343(12):884; author reply 885. doi: 10.1056/NEJM200009213431211. N Engl J Med. 2000. PMID: 11001684 No abstract available.
• Levodopa in the treatment of Parkinson's disease: current controversies.

  Gerlach M, Reichmann H, Riederer P. Gerlach M, et al. Mov Disord. 2005 May;20(5):643; author reply 643-4. doi: 10.1002/mds.20435. Mov Disord. 2005. PMID: 15732130 No abstract available.
• [Pharmacological therapy of complicated Parkinson's disease].

  Jiménez-Jiménez FJ, Molina JA. Jiménez-Jiménez FJ, et al. Rev Neurol. 1997 Aug;25 Suppl 2:S170-9. Rev Neurol. 1997. PMID: 9280685 Review. Spanish.
• [Parkinson syndrome: iatrogenic causes, iatrogenic treatment results].

  Burgunder JM. Burgunder JM. Schweiz Med Wochenschr. 1996 Mar 30;126(13):522-7. Schweiz Med Wochenschr. 1996. PMID: 8658091 Review. German.